4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol has been researched along with u-50488 in 1 studies
Studies (4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol) | Trials (4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol) | Recent Studies (post-2010) (4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol) | Studies (u-50488) | Trials (u-50488) | Recent Studies (post-2010) (u-50488) |
---|---|---|---|---|---|
70 | 12 | 9 | 1,664 | 3 | 209 |
Protein | Taxonomy | 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol (IC50) | u-50488 (IC50) |
---|---|---|---|
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 2.15 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0027 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 2.15 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.7171 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0958 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.0537 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Amata, E; Artacho-Cordón, A; Barbaraci, C; Cobos, EJ; Dichiara, M; Gómez-Guzmán, M; González-Cano, R; Marrazzo, A; Pasquinucci, L; Rodríguez-Gómez, I; Santos-Caballero, M; Turnaturi, R | 1 |
1 other study(ies) available for 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol and u-50488
Article | Year |
---|---|
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.
Topics: Animals; Guinea Pigs; Hydrogen; Hydrogen Sulfide; Ligands; Male; Morpholines; Pain; Piperazines; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor | 2022 |